AC
Ascend Capital’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-43,945
| Closed | -$12.8M | – | 179 |
|
2018
Q2 | $12.8M | Buy |
43,945
+30,974
| +239% | +$8.99M | 0.6% | 58 |
|
2018
Q1 | $3.55M | Buy |
+12,971
| New | +$3.55M | 0.14% | 135 |
|
2017
Q3 | – | Sell |
-66,053
| Closed | -$17.9M | – | 168 |
|
2017
Q2 | $17.9M | Buy |
+66,053
| New | +$17.9M | 0.83% | 42 |
|
2016
Q3 | – | Sell |
-5,070
| Closed | -$1.23M | – | 123 |
|
2016
Q2 | $1.23M | Sell |
5,070
-4,930
| -49% | -$1.19M | 0.08% | 127 |
|
2016
Q1 | $2.6M | Sell |
10,000
-136,225
| -93% | -$35.5M | 0.25% | 77 |
|
2015
Q4 | $44.8M | Buy |
146,225
+66,345
| +83% | +$20.3M | 1.58% | 16 |
|
2015
Q3 | $23.3M | Buy |
79,880
+10,696
| +15% | +$3.12M | 0.91% | 39 |
|
2015
Q2 | $27.9M | Buy |
+69,184
| New | +$27.9M | 0.92% | 42 |
|
2015
Q1 | – | Sell |
-40,313
| Closed | -$13.7M | – | 170 |
|
2014
Q4 | $13.7M | Sell |
40,313
-55,083
| -58% | -$18.7M | 0.53% | 64 |
|
2014
Q3 | $31.6M | Buy |
+95,396
| New | +$31.6M | 0.93% | 41 |
|
2014
Q2 | – | Sell |
-10,010
| Closed | -$3.06M | – | 171 |
|
2014
Q1 | $3.06M | Sell |
10,010
-196,949
| -95% | -$60.2M | 0.08% | 163 |
|
2013
Q4 | $57.9M | Buy |
206,959
+119,519
| +137% | +$33.4M | 1.76% | 10 |
|
2013
Q3 | $21.1M | Buy |
+87,440
| New | +$21.1M | 0.78% | 40 |
|